Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuanfei Baidu Granule for Influenza A
NCT06205641Recruiting
- Sponsor
- Capital Medical University
- Start
- Jan 2024
- Primary completion
- Jun 2024
- Modality
- TCM (Traditional Chinese Medicine)
- Countries
- 1
01
Overview
Randomised trial of Xuanfei Baidu in Influenza A (IAV) (4 arms), sponsored by Capital Medical University. Primary endpoint: The time to fever resolution at 7 days. Started Jan 2024; status: recruiting.
02
Drugs
Xuanfei Baidu
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT06205641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06205641.